Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Nurix Therapeutics Inc
NASDAQ:NRIX
Nurix Therapeutics Inc
NASDAQ:NRIX
Price:
15.24
USD
-40.98%
Market Closed
Market Cap:
$1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
US |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
CN |
|
E
|
E79 Gold Mines Ltd
ASX:E79
|
AU |
|
V
|
Vinci SA
XHAN:SQU
|
FR |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
Bumi Resources Minerals Tbk PT
IDX:BRMS
|
ID |
|
E
|
Electromagnetic Geoservices ASA
F:E2M
|
NO |
|
L
|
Liontown Ltd
SWB:LIS
|
AU |
|
V
|
Vinci SA
F:SQU
|
FR |
|
X
|
Xaar PLC
OTC:XAARF
|
UK |
|
S
|
S&D Co Ltd
KOSDAQ:260970
|
KR |
Wall St Price Targets
NRIX Price Forecast
Based on 16 analysts
Based on 16 analysts
+134% Upside
from
$15.24
today
Nurix Therapeutics Inc (NRIX)’s 12-month stock price forecast through November 2027 has a consensus target of $35.7, implying 134% upside. The forecast is based on price targets from 16 Wall Street analysts.
NRIX Analyst Rating
Based on 14 analysts
Based on 14 analysts
Analysts rate NRIX Strong buy, with 13 of 14 recommending Buy or Strong buy.
Nurix Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NRIX's stock price target?
Price Target
35.7
USD
35.7
USD
According to Wall Street analysts, the average 1-year price target for NRIX is 35.7 USD with a low forecast of 25.25 USD and a high forecast of 47.25 USD.
What is the Revenue forecast for Nurix Therapeutics Inc?
Projected CAGR
46%
46%
Over the last 6 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 8 years is 46%.
